Department of Orthopaedic Surgery, University of California, Los Angeles, Santa Monica, CA, USA.
David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Cartilage. 2021 Jul;12(3):333-343. doi: 10.1177/1947603519841673. Epub 2019 Apr 11.
Successful clinical outcomes following cartilage restoration procedures are highly dependent on addressing concomitant pathology. The purpose of this study was to document methods for evaluating concomitant procedures of the knee when performed with articular cartilage restoration techniques, and to review their reported findings in high-impact clinical orthopedic studies. We hypothesized that there are substantial inconsistencies in reporting clinical outcomes associated with concomitant procedures relative to outcomes related to isolated cartilage repair.
A total of 133 clinical studies on articular cartilage repair of the knee were identified from 6 high-impact orthopedic journals between 2011 and 2017. Studies were included if they were primary research articles reporting clinical outcomes data following surgical treatment of articular cartilage lesions with a minimum sample size of 5 patients. Studies were excluded if they were review articles, meta-analyses, and articles reporting only nonclinical outcomes (e.g., imaging, histology). A full-text review was then used to evaluate details regarding study methodology and reporting on the following variables: primary cartilage repair procedure, and the utilization of concomitant procedures to address additional patient comorbidities, including malalignment, meniscus pathology, and ligamentous instability. Each study was additionally reviewed to document variation in clinical outcomes reporting in patients that had these comorbidities addressed at the time of surgery.
All studies reported on the type of primary cartilage repair procedure, with autologous chondrocyte implantation (ACI) noted in 43% of studies, microfracture (MF) reported in 16.5%, osteochondral allograft (OCA) in 15%, and osteochondral autograft transplant (OAT) in 8.2%. Regarding concomitant pathology, anterior cruciate ligament (ACL) reconstruction (24.8%) and meniscus repair (23.3%) were the most commonly addressed patient comorbidities. A total of 56 studies (42.1%) excluded patients with malalignment, meniscus injury, and ligamentous instability. For studies that addressed concomitant pathology, 72.7% reported clinical outcomes separately from the cohort treated with only cartilage repair. A total of 16.5% of studies neither excluded nor addressed concomitant pathologies. There was a significant amount of variation in the patient reported outcome scores used among the studies, with the majority of studies reporting International Knee Documentation Committee (IKDC) and Knee Injury and Osteoarthritis Outcomes Score (KOOS) in 47.2% and 43.6% of articles, respectively.
In this study on knee cartilage restoration, recognition and management of concomitant pathology is inadequately reported in approximately 28% of studies. Only 30% of articles reported adequate treatment of concomitant ailments while scoring their outcomes using one of a potential 18 different scoring systems. These findings highlight the need for more standardized methods to be applied in future research with regard to inclusion, exclusion, and scoring concomitant pathologies with regard to treatment of cartilage defects in the knee.
软骨修复术后的临床结果是否成功高度依赖于对并存病理的处理。本研究旨在记录当使用关节软骨修复技术时评估膝关节并存手术的方法,并回顾高影响力临床骨科研究中对其的报道结果。我们假设,与单独的软骨修复相关的结果相比,与并存手术相关的临床结果报告存在很大的不一致。
2011 年至 2017 年,我们从 6 种高影响力的骨科期刊中确定了总共 133 项关于膝关节关节软骨修复的临床研究。如果研究是报告了手术治疗关节软骨病变后临床结果数据的主要研究文章,且样本量至少为 5 例,则将其纳入研究。如果研究为综述文章、荟萃分析或仅报告非临床结果(如影像学、组织学),则将其排除。然后进行全文审查,以评估以下变量的研究方法和报告的详细信息:主要软骨修复程序,以及利用并存程序来解决其他患者合并症,包括对线不良、半月板病变和韧带不稳定。此外,还对每项研究进行了审查,以记录在手术时解决这些合并症的患者的临床结果报告中的差异。
所有研究均报告了原发性软骨修复程序的类型,其中自体软骨细胞移植(ACI)占 43%,微骨折(MF)占 16.5%,骨软骨同种异体移植(OCA)占 15%,骨软骨自体移植(OAT)占 8.2%。关于并存病理,前交叉韧带(ACL)重建(24.8%)和半月板修复(23.3%)是最常见的患者合并症。共有 56 项研究(42.1%)排除了对线不良、半月板损伤和韧带不稳定的患者。对于处理并存病理的研究,72.7%的研究将临床结果与仅接受软骨修复的队列分开报告。共有 16.5%的研究既未排除也未处理并存病理。在使用的患者报告结局评分中存在很大的差异,其中大多数研究分别报告国际膝关节文献委员会(IKDC)和膝关节损伤和骨关节炎结局评分(KOOS),分别占 47.2%和 43.6%的文章。
在这项关于膝关节软骨修复的研究中,大约 28%的研究中对并存病理的认识和处理报告不足。只有 30%的文章在使用潜在的 18 种不同评分系统之一对并存疾病进行评分的同时,充分治疗了这些疾病。这些发现强调需要在未来的研究中应用更标准化的方法,以纳入、排除和评分膝关节软骨缺损治疗中的并存疾病。